Blog Article
If you are exploring weight management options through a telehealth provider, you may have come across both semaglutide and tirzepatide. These medications are often discussed together because they share several characteristics, but they are not identical. Here is what sets them apart and what that means for patients going through a clinical review process.
What They Have in Common
Both semaglutide and tirzepatide are:
- Administered as once-weekly subcutaneous injections
- Prescribed as part of a provider-guided weight management plan
- Used alongside nutrition and physical activity guidance
- Dosed gradually, starting low and increasing over time under provider direction
- Compounded versions that are not FDA-approved for safety, effectiveness, or quality
Both medications work by influencing how the body responds to food, reducing appetite, slowing digestion, and supporting blood sugar regulation.
How Semaglutide Works
Semaglutide is a GLP-1 receptor agonist, meaning it mimics the GLP-1 hormone that your body naturally produces after eating. This hormone signals the brain to reduce hunger, prompts the pancreas to release insulin, and slows the rate at which food leaves the stomach. The combined effect is a reduction in caloric intake that feels less like restriction and more like a reset in how the body experiences hunger.
How Tirzepatide Works
Tirzepatide is a dual agonist. In addition to activating GLP-1 receptors, it also activates GIP receptors, GIP being another gut hormone involved in insulin regulation and fat metabolism. This dual-action mechanism gives tirzepatide a somewhat different metabolic profile than semaglutide alone. Clinical research has shown strong weight management outcomes with tirzepatide, though individual response depends on health history, eligibility, and provider evaluation.
Key Differences at a Glance
- Mechanism: Semaglutide targets one receptor (GLP-1). Tirzepatide targets two (GLP-1 and GIP).
- Metabolic profile: Tirzepatide's dual action may have a broader effect on fat metabolism and insulin sensitivity.
- Clinical outcomes: Both have shown meaningful weight loss results; outcomes vary by individual.
- Side effect profiles: Both can cause gastrointestinal side effects, most commonly early in treatment during dose escalation. Experiences differ from person to person.
Which One Is Right for You?
This is not a decision to make based on a blog post. The right medication, dose, and treatment plan for you depends on your individual health history, current conditions, medications you may be taking, and other factors that only a licensed provider can assess. During EPIC Health's intake and clinical review process, your provider will evaluate whether either medication is appropriate and, if so, which approach best fits your situation.
Starting the Conversation
If you meet basic eligibility criteria, such as a BMI of 30 or higher, or 27 or higher with a weight-related health condition, and you have had difficulty achieving your goals through diet and physical activity alone, a GLP-1 medication may be worth discussing with a provider. EPIC Health's process begins with a medical intake form followed by a clinical provider review, giving you access to personalized guidance rather than a generic plan.
The information in this article is for educational purposes only and does not constitute medical advice. All treatment decisions are made between patients and licensed healthcare providers.
Clinician-Guided Medical Weight Loss
Achieve sustainable weight loss with clinician-guided medical treatments tailored to your body, goals, and health history. Our approach combines medical review, personalized dosing, and ongoing support using modern, evidence-based therapies.
.svg)